This paper is only available as a PDF. To read, Please Download here.
The influence of CG 4203, a chemically and metabolically stable prostacyclin analogue, on plasma renin activity, arterial blood pressure, renal function and water intake was investigated in conscious rats. CG 4203 infused intravenously starting at 1 μg·kg−1·min−1 induced both a fall in blood pressure and an increase of plasma renin activity. The angiotensin II antagonist saralasine infused simultaneously intensified the hypotensive effect of CG 4203 (1.0 μg·kg−1·min−1. Within a similar dose range CG 4203 dose-dependently inhibited diuresis and saluresis and reduced the urinary sodium/potassium ratio. These effects were partially reversed by adrenalectomy and completely abolished by pretreatment with the angiotensin I converting enzyme inhibitor captopril. Similarly, CG 4203 (0.21 – 4.64 μg·kg−1·min−1 ) dose-dependently caused increased water intake which was prevented by previous nephrectomy. In conclusion, it is demonstrated that CG 4203 like prostacyclin itself already at hypotensive threshold dosages stimulates a functionally relevant renin release. The activation of the renin-angiotensin-aldosterone system attenuates the intrinsic hypotensive effects of CG 4203. The antidiuretic and dipsogenic efficacy of CG 4203 can also be attributed to renin-dependent angiotensin II formation.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Prostaglandins, Leukotrienes and Essential Fatty Acids
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Plasmarenin activity and vasodepressor action of prostacyclins with modified -side chain in anaesthetized rats.Prostaglandins and Medicine. 1980; 4: 357
- Prostaglandins and renin production: a review.Prostaglandins. 1980; 20: 1131
- Structure-activity relationship of PGI2 analogs.in: 1st Intern. Austrian Prostaglandin Meeting, Bad Ischl1982
- CG 4203 (New stable prostacyclin analogue): effect on bleeding time and blood coagulation.in: 1st Intern. Austrian Prostaglandin Meeting, Bad Ischl1982
- CG 4203 (New stable prostacyclin analogue): actions on platelets and blood pressure.in: 1st Intern. Austrian Prostaglan din Meeting, Bad Ischl1982
- CG 4203 (New stable prostacyclin analogue): cardiovascular profile in anaesthetized rabbits.in: 1st Intern. Austrian Prostaglandin Meeting, Bad Ischl1982
- Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.J. Clin. Endocrinol. Metab. 1969; 29: 1349
- The cardiovascular pharmacology of prostacyclin in the rat.Prostaglandins. 1979; 17: 501
- Renal hemodynamics in acute and chronic angiotensin II hypertension.Am. J. Physiol. 1978; 236: F174
- Hypertensive and renal effects of chronic low level intrarenal angiotensin infusion in the dog.Circ. Res. 1979; 44: 154
- Effects of prostaglandin E2, I2 and F2α on systemic and renal hemodynamics, renal function and renin secretion in anesthetized dogs.Japan. J. Pharmacol. 1980; 30: 173
- Thirst.Physiol. Rev. 1972; 52: 468
- The renin angiotensin system and drinking behaviour.Progr. Brain Res. 1975; 42: 215
- The pharmacologic alteration of renin release.Pharmacol. Rev. 1981; 31: 81
- Prostaglandins and renin release: I. Stimulation of renin release from rabbit renal cortical slices by PGI2.Prostaglandins. 1977; 14: 1095
© 1983 Published by Elsevier Inc.